Figure 2.

Most frequently used oral hypoglycemic medications (dark green) in kidney transplantation, with the main advantages (light green) and concerns (light orange). BMI, body mass index; CV, cardiovascular; CVD, cardiovascular disease; CYP2C9, cytochrome P450 family 2 subfamily C member 9; GFR, glomerular filtration rate; GI, gastrointestinal; DPP-4i, dipeptidyl peptidase-4 inhibitors GLP-1 RA, glucagon-like peptide-1 receptor agonists; IST, immunosuppressive therapy; SGLT-2i, sodium glucose cotransporter-2 inhibitors.